Related references
Note: Only part of the references are listed.osDesign: AnRPackage for the Analysis, Evaluation, and Design of Two-Phase and Case-Control Studies
Sebastien Haneuse et al.
Journal of Statistical Software (2015)
Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy
Erin E. Gabriel et al.
BIOSTATISTICS (2014)
Evaluating Immune Correlates in HIV Type 1 Vaccine Efficacy Trials: What RV144 May Provide
Morgane Rolland et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Nomenclature for Immune Correlates of Protection After Vaccination
Stanley A. Plotkin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Sample size and power determination in joint modeling of longitudinal and survival data
Liddy M. Chen et al.
STATISTICS IN MEDICINE (2011)
Using the Whole Cohort in the Analysis of Case-Cohort Data
Norman E. Breslow et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Evaluating Candidate Principal Surrogate Endpoints
Peter B. Gilbert et al.
BIOMETRICS (2008)
A framework for assessing immunological correlates of protection in vaccine trials
Li Qin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Improving the efficiency of relative-risk estimation in case-cohort studies
M Kulich et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
Sample size/power calculation for case-cohort studies
JW Cai et al.
BIOMETRICS (2004)
Power and sample size calculations for generalized regression models with covariate measurement error
TD Tosteson et al.
STATISTICS IN MEDICINE (2003)
Exposure stratified case-cohort designs
O Borgan et al.
LIFETIME DATA ANALYSIS (2000)
Share Paper
